Conducting clinical research studies with
SKILL, KNOWLEDGE and SAFETY.
Call to participate
860.443.4567

Archive for the ‘ Dr. Radin ’ Category

November is Alzheimer’s Awareness Month

Thursday, November 2nd, 2017

 

CCRstudies is a member of the Alzheimer’s Foundation of America.

November is national Alzheimer’s Awareness Month.

Here at Coastal Connecticut Research, we’ve been heavily involved in the fight against Alzheimer’s.  We have conducted a variety of Alzheimer’s clinical research studies with primary investigator Dr. Laurence Radin, who specializes in neurology.  We have also provided community members with no cost memory screenings

as a public service through the Alzheimer’s Foundation of America’s early detection program.  To date, over 100 no cost screenings have been offered to the public through our Mobile Memory Clinics.

Over 5 million Americans are living with Alzheimer’s disease, a progressive, degenerative condition.  Research will continue to help discover and  develop improved treatments for individuals living with memory loss.

If you or someone you know is living with memory loss, has a family history of memory loss, or would like to learn more about research involving memory loss, call to speak to a member of the CCRstudies team at (860) 443-4567 or email marylou@ccrstudies.com. 

 

Migraine Headaches

Thursday, May 25th, 2017

For years, Susan had been living with incapacitating headaches that sometimes caused her to miss work or family events.  The headaches began in her late teens and have lasted until now, her mid-30’s.  Sometimes the headaches would start on a Monday and stretch all the way until Wednesday.  Quite frequently with these headaches Susan would experience nausea, as well as sensitivity to lights and sounds.  When these headaches came on, Susan would turn off all the lights, avoid people and hunker down.  What Susan did not realize is her headaches were in fact migraines!

Not everyone who lives with migraine headaches realize they are in fact getting a migraine.  3 million Americans are currently suffering with this condition.  Vision can become blurred, people can experience fatigue, stomach upset, and intense, throbbing pain.

Research is underway in New London testing an investigational medication for the prevention of migraine headaches. Dr. Laurence Radin, Dr. Edward McDermott, and Andrea Stewart APRN are members of a  Migraine Prevention Study  research team in New London. Individuals living with migraine headaches who may wish to learn more about this 9-month research study are welcome to call to speak with a member of the CCRstudies team at (860) 443-4567 or email marylou@ccrstudies.com.

 

Migraine Headache Research

Thursday, January 19th, 2017

Research will be underway shortly in New London to test the safety and efficacy of a migraine prevention treatment.  Currently 3 million Americans report they suffer with migraine headaches. Migraine symptoms can range from moderate to severe and the headaches can start as early as childhood or young adulthood.

When someone is suffering from a migraine, they may experience nausea, blurred vision or auras, a sensitivity to lights, sounds, and odors, as well as a persistent throbbing pain behind the eyes or temples. A migraine can be “the mother of all headaches” in regards to the sometimes crippling pain.  This pain may be present on one of both sides of the head.  A migraine can last anywhere from 4 to 72 hours.  Researchers have taken a look at a variety of factors that might lead to a migraine including the chemical balance in the brain, hormonal fluctuations and reactions to food, environment and stress among other contributors.

Dr. Laurence Radin, New London neurologist, will serve as the Migraine Prevention study’s Primary Investigator. His team will consist of Andrea Stewart APRN and Jessie Hatfield LPN.  The study will be conducted at Coastal Connecticut Research in New London.  Those interested in learning more can call and speak to a member of the CCRstudies team at (860)443-4567 or email marylou@ccrstudies.com.

Observational Alzheimer’s Study

Tuesday, October 4th, 2016

Volunteers are needed for an exploratory, observational clinical study for memory loss in New London.  The study is looking to see if having markers for dementia, such as brain wave patterns, blood, and cognition will help diagnose and monitor Alzheimer’s Disease more easily and earlier in the future.  Coastal Connecticut Research is seeking individuals in the early stages of memory loss to participate in this clinical research trial.

If you or someone you know living with dementia is under the age of 90, you may be eligible to participate in this clinical research study.  Neurologist Dr. Laurence Radin is the study doctor.  The study team is comprised of highly trained nurses and Qualified Dementia Care Specialists.

Study tests are non-invasive.  All study-related labs, exams and testing are provided at no cost.  No insurance is required. Reimbursement is available for time and travel.  If you have questions or interest in this study, contact a member of the CCRstudies team at (860)443-4567 or email marylou@ccrstudies.com.

Observational Alzheimer’s Study

Tuesday, July 5th, 2016
Alzheimer’s patients and healthy volunteers are needed to participate in an exploratory, observational clinical study being conducted in New London at Coastal Connecticut Research. New London County Neurologist Dr. Laurence Radin is the study doctor. The intent of the study is to help diagnose and monitor Alzheimer’s Disease more easily and earlier in the fut
Those who may be eligible to participate in the study are living with mild to moderate memory loss and under the age of 90.
There are 2 study visits over the course of 1 year.  No study drug is involved. The Alzheimer’s patient can continue with his or her usual medication and diet as normal.
There is no cost to participate in this clinical research study, no insurance is needed, and reimbursement is available to the study patient for time and travel. Study tests are non-invasive and are provided at no cost.  Study procedures, including an MRI (if needed) and a EEG are performed at no cost.
If you are interested in participating as an Alzheimer’s patient or as a healthy volunteer, please contact a member of the CCRstudies team today at (860)443-4567 or email marylou@ccrstudies.com. Referrals are also welcome.
Coastal Connecticut Research is a member of the Alzheimer’s Foundation of America.Flyer with CCR contact information US Spelling

Alzheimer’s Study

Wednesday, November 25th, 2015

STARBEAM STUDY Postcard CCR

Alzheimer’s is a progressive disease of the brain. Brian cells die over a period of several years, and symptoms progress from mild to severe.  Alzheimer’s is one of the leading causes of death in the U.S., and affects over 5 million Americans.

It has been over a decade since the FDA has approved any new medications for the treatment of Alzheimer’s.  Clinical research is currently underway in New London at CCRstudies, testing an investigational add-on medication. The team of investigators includes Laurence Radin, MD, Edward McDermott, Jr., MD, and Andrea Stewart, APRN.   This medication is taken in conjunction with the study patients current dosage of Aricept (Donepezil.)  The investigational medication is designed to improve thinking, memory, reasoning and cognition.  It is the Phase 3 of the clinical trial process.

Those interested in learning more about the Alzheimer’s study underway in New London can contact a member of the CCRstudies team at (860)443-4567, or click on this link for further details  https://www.youtube.com/watch?v=l1LgVnQ3pqU.

In addition to the study patient, caregivers play an important role in this trial.  There is no cost to participate and compensation is available for time and travel to the study patient and caregiver.

Alzheimer’s Awareness

Friday, October 30th, 2015
CCRstudies is a member of the Alzheimer's Foundation of America.

CCRstudies is a member of the Alzheimer’s Foundation of America.

November is National Alzheimer’s Awareness Month. Volunteers are needed for an Alzheimer’s study being conducted in New London by Dr. Laurence Radin, Dr. Edward McDermott, and Andrea Stewart, APRN.

Alzheimer’s disease is the most common form of dementia in adults 65 and over.  Dementia is a general term which describes a group of symptoms related to the loss of a variety of intellectual functions.  This can include loss in memory, judgment, language and complex motor skills which may interfere with daily living.

The Alzheimer’s Foundation of America notes that “Alzheimer’s disease is not a normal part of aging: however, age is the greatest known risk factor.  Other factors are genetic makeup and chronic untreated health problems such as high blood pressure.”

There is no cure currently available for Alzheimer’s disease, but there are FDA-approved medications available that can help to slow the progression of disease symptoms.

Research is currently underway in New London testing an investigational add-on medication for the treatment of Alzheimer’s. Volunteers with mild to moderate memory loss currently taking Aricept are needed as potential study volunteers. There has been no new medication introduced for the treatment of Alzheimer’s in over a decade.  If you or someone you know, ages 50 or above, is living with mild to moderate memory loss, you may qualify for this research study.  Call a member of the CCRstudies Team at 860-443-4567 today to learn more about how you can be involved in research.  Study participants and caregivers are eligible to receive compensation for their time and travel in addition to no cost study-related care.

MS Spasticity

Monday, October 26th, 2015

Multiple Sclerosis is said to effect over 400,000 Americans.  Worldwide at least 2.5 million people are living with MS.  MS spasticity is a condition in which the individual with MS experiences tightness, stiffness or a pull of the muscles.

CCRstudies currently has a clinical trial underway testing an investigational medication similar to a currently approved medication, Baclofen. The study medication is being evaluated to determine whether an extended release (ER) medication is effective at treating spasticity with a once daily dosing after your evening meal.

If you are taking Baclofen for your spasticity, you may be interested in seeing if you are eligible to participate in the research trial taking place in New London.  Dr. Laurence Radin is the Primary Investigator, assisted by Sub-Investigator Andrea Stewart, APRN. Both are members of the research team at CCRstudies and are members of Neurological Group, PC in New London.

Study medication, study-related exams and lab testing are at no cost.

Contact a member of the CCRstudies team to see if you may qualify to participate in the clinical research trial. 860-443-4567.

Mobile Memory Clinic

Thursday, October 1st, 2015

 

Residents of Hamilton Park

Residents of Hamilton Park

CCRstudies had the pleasure of taking our show on the road to kick off the month of October.  We conducted a presentation on Alzheimer’s research at the Hamilton Park Apartments in Norwich.  Following the presentation, free memory screenings were held for interested residents as part of the Alzheimer’s Foundation of America’s early detection/screening initiative.

Residents in attendance were gracious and attentive and not only appreciated the information presented, but also had some fun with our free giveaways!  The Alzheimer’s presentation was interactive, and residents asked questions throughout such as “if I lose my keys all the time, does this mean I am losing my mind?” and, “what’s the difference between being senile, having dementia, and having Alzheimer’s?”  People shared their stories of caring for loved ones with Alzheimer’s, and noted how eager they were to participate in the early detection memory screening. Virtually all in attendance had an anecdote to share about someone in their life living with memory disease.  A big “thank you” goes out Tara Dowling of Hamilton Park who invited us to facilitate the event.  We look forward to further connecting with the Norwich community!

Alzheimer’s Talk on the Air

Monday, August 31st, 2015

Recently, CCRstudies had the good fortune of going on the Lee Elci Radio Show on 94.9 News Now.  Lee, an affable host, allowed CCR’s MaryLou Gannotti, Public Relations and Communications Director, to have an open discussion on Alzheimer’s Disease, including promoting CCRstudies no cost memory testing through the Alzheimer’s Foundation of America. MaryLou also talked about the STARBEAM study, a clinical research trial testing an investigation add-on medication for those living with mild to moderate Alzheimer’s Disease.

To hear more, click on the play button below:

To learn more about CCRstudies Free Memory Testing, or the STARBEAM study, call 860-443-4567 or email marylou@ccrstudies.com.